Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives January 14, 2018 Johnson & Johnson Employee Pleads With CEO, Lawmakers to Help Save DACA January 11, 2018 Cambridge's WuXi NextCODE Completes a Whopping $240 Million Funding Round September 6, 2017
